Top

Osteoporosis International

Published in:

Open Access 01-01-2021 | Osteoporosis | Original Article

Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women

Authors: D. Ozaki, R. Kubota, T. Maeno, M. Abdelhakim, N. Hitosugi

Published in: Osteoporosis International | Issue 1/2021

Abstract

Introduction

We investigated the relationship between gut microbiota composition and osteoporosis/fracture risk in Japanese postmenopausal women using 16S rRNA gene sequencing, FRAX, bone mineral density, biochemical bone parameters, and a self-administered questionnaire. Variation in abundance of specific microbiota was found to be significantly associated with fracture risk and vitamin K levels.

Gut microbiota data with respect to bone metabolism and fracture risk is limited. Vitamin K is produced by certain intestinal bacteria and has been reported to play a role in maintaining bone quality.

Purpose

We investigated relationships among gut microbiota composition, bone metabolism, and fracture risk in postmenopausal Japanese women.

Methods

Bone mineral density (BMD) was evaluated in 38 postmenopausal women (mean age 62.9 years) using forearm dual-energy X-ray absorptiometry. We collected and analyzed serum bone turnover markers (vitamin K fraction and tartrate-resistant acid phosphatase 5b; TRACP-5b), gut microbiota profiling (16S rRNA gene sequencing), and self-administered questionnaire data, including fracture history and vitamin K intake. Vitamin K2, BMD, and TRACP-5b data were divided into high- and low-level groups using cutoff values of 0.06 ng/mL, 87.05%, and 420 mU/dL, respectively; the proportions of bacteria were analyzed. Fracture incidence and relative risk were investigated for each bacterium.

Results

The genus Bacteroides was predominant in the high vitamin K2 group (29.73% vs 21.58%, P = 0.022). Fracture incidence was significantly higher in the low Bacteroides group, with a 5.6-times higher risk ratio of fracture history.

The family Rikenellaceae was more abundant in the low BMD group and more abundant in the high TRACP-5b group (2.15% vs 0.82%, P = 0.004; 2.38% vs 1.12%, P = 0.013, respectively).

Conclusion

Bacteroides and Rikenellaceae may be involved in bone metabolism and fracture risk. Further investigations of the underlying microbiota-related pathways in bone metabolism may reveal treatment strategies, and facilitate the prevention of osteoporosis.

Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://doi.org/10.1007/s00774-009-0080-8CrossRefPubMed

Orimo H, Nakamura T, Hosoi T et al (2015) [Japanese 2015 guidelines for prevention and treatment of osteoporosis.]:4-5[Article in Japanese] http://www.josteo.com/ja/guideline/doc/15_1.pdf

Kanis JA (2007) Assessment of osteoporosis at the primary health care level. Technical Report World Health Organization Collaborating Centre for Metabolic Bone Diseases; University of Sheffield, United Kingdom. https://www.sheffield.ac.uk/FRAX/

Iki M (2012) Epidemiology of osteoporosis in Japan. Clin Calcium 22:797–803 [Article in Japanese]PubMed

Frank DN, Amand ALS, Feldman RA, Boedeker EC, Harpaz N, Pace NR (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 21(104):13780–13785. https://doi.org/10.1073/pnas.0706625104CrossRef

Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, Ugarte E, Muñoz-Tamayo R, Paslier DLE, Nalin R, Dore J, Leclerc M (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11:2574–2584. https://doi.org/10.1111/j.1462-2920.2009.01982.xCrossRefPubMed

Bibbò S, Ianiro G, Giorgio V, Scaldaferri F, Masucci L, Gasbarrini A, Cammarota G (2016) The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci 20:4742–4749 https://www.europeanreview.org/article/11780PubMed

Swidsinski A, Loening-Baucke V, Lochs H, Hale LP (2005) Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 11:1131–1140. https://doi.org/10.3748/wjg.v11.i8.1131CrossRefPubMedPubMedCentral

Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE (2006) Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(min/+) mice. Cancer Res 66:57–61. https://doi.org/10.1158/0008-5472.CAN-05-3445CrossRefPubMed

10.

Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, Takahashi T, Miyauchi S, Shioi G, Inoue H, Tsujimoto G (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4:1829. https://doi.org/10.1038/ncomms2852CrossRefPubMed

11.

Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109–1113. https://doi.org/10.1038/nature07336CrossRefPubMedPubMedCentral

12.

Marin IA, Goertz JE, Ren T, Rich SS, Onengut-Gumuscu S, Farber E, Wu M, Overall CC, Kipnis J, Gaultier A (2017) Microbiota alteration is associated with the development of stress-induced despair behavior. Sci Rep 7:43859. https://doi.org/10.1038/srep43859CrossRefPubMedPubMedCentral

13.

Sampson TR, Debelius JW, Thron T et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167:1469–1480.e12. https://doi.org/10.1016/j.cell.2016.11.018CrossRefPubMedPubMedCentral

14.

Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Núñez G, Shibuya A (2014) Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe 15:95–102. https://doi.org/10.1016/j.chom.2013.12.010CrossRefPubMedPubMedCentral

15.

Wang J, Wang Y, Gao W, Wang B, Zhao H, Zeng Y, Ji Y, Hao D (2017) Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. Peer J 5:e3450. https://doi.org/10.7717/peerj.3450CrossRefPubMedPubMedCentral

16.

Geirnaert A, Wang J, Tinck M et al (2015) Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model. FEMS Microbiol Ecol 91:fiv054. https://doi.org/10.1093/femsec/fiv054CrossRefPubMed

17.

Roux AL, El Sayed F, Duffiet P et al (2015) Ruminococcus gnavus total hip arthroplasty infection in a 62-year-old man with ulcerative colitis. J Clin Microbiol 53:1428–1430. https://doi.org/10.1128/JCM.03040-14CrossRefPubMedPubMedCentral

18.

Ando A (2015) Gut microbiota as a new organ. Clin J Gastroenterol 112:1939–1946(B). [Article in Japanese]. https://doi.org/10.11405/nisshoshi.112.1939CrossRef

19.

Halleen JM, Alatalo SL, Janckila AJ et al (2001) Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 47:597–600. https://doi.org/10.1093/clinchem/47.3.597CrossRefPubMed

20.

DeSantis TZ, Hugenholtz P, Larsen N et al (2006) Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72:5069–5072. https://doi.org/10.1128/AEM.03006-05CrossRefPubMedPubMedCentral

21.

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335–336. https://doi.org/10.1038/nmeth.f.303CrossRefPubMedPubMedCentral

22.

Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 26:2460–2461. https://doi.org/10.1093/bioinformatics/btq461CrossRefPubMed

23.

Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM (2009) The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37:D141–D145. https://doi.org/10.1093/nar/gkn879CrossRefPubMed

24.

Kono S, Sunagawa Y, Higa H, Sunagawa H (1990) Age of menopause in Japanese women: trends and recent changes. Maturitas 12:43–49. https://doi.org/10.1016/0378-5122(90)90059-FCrossRefPubMed

25.

Kamao M, Suhara Y, Tsugawa N et al (2007) Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol 53:464–470. https://doi.org/10.3177/jnsv.53.464CrossRefPubMed

26.

Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C (2007) Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 109:3279–3283. https://doi.org/10.1182/blood-2006-08-040709CrossRefPubMed

27.

Guss JD, Taylor E, Rouse Z et al (2019) The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength. Bone 127:146–154. https://doi.org/10.1093/ajcn/69.1.74CrossRefPubMedPubMedCentral

28.

Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA (1999) Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69:74–79. https://doi.org/10.1093/ajcn/69.1.74CrossRefPubMed

29.

Fusaro M, Mereu MC, Aghi A, Iervasi G, Gallieni M (2017) Vitamin K and bone. Clin Cases Miner Bone Metab 14:200–206. https://doi.org/10.11138/ccmbm/2017.14.1.200CrossRefPubMedPubMedCentral

30.

Zhang H-h, Liu J, Lv Y-j, Jiang Y-l, Pan J-x, Zhu Y-j, Huang M-g, Zhang S-k (2019) Changes in intestinal microbiota of type 2 diabetes in mice in response to dietary supplementation with instant tea or matcha. Can J Diabetes 44:44–52. https://doi.org/10.1016/j.jcjd.2019.04.021CrossRefPubMed

31.

Park SJ, Kim J-H, Kim J-H et al (2017) PD-1 deficiency protects experimental colitis via alteration of gut microbiota. BMB Rep 50(11):578–583. https://doi.org/10.5483/BMBRep.2017.50.11.165CrossRefPubMedPubMedCentral

32.

Hannelore D, Amin MG, David B at al. (2014) High-fat diet alters gut microbiota physiology in mice. ISME J 8:295–308. https://doi.org/10.1038/ismej.2013.155CrossRef

33.

Kurakawa T, Ogata K, Matsuda K, Tsuji H, Kubota H, Takada T, Kado Y, Asahara T, Takahashi T, Nomoto K (2015) Diversity of intestinal Clostridium coccoides group in the Japanese population, as demonstrated by reverse transcription-quantitative PCR. PLoS One 10:e0126226. https://doi.org/10.1371/journal.pone.0152753CrossRefPubMedPubMedCentral

34.

Rondanelli M, Giacosa A, Faliva MA, Perna S, Allieri F, Castellazzi AM (2015) Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases 3:156–162. https://doi.org/10.12998/wjcc.v3.i2.156CrossRefPubMedPubMedCentral

35.

Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085. https://doi.org/10.1371/journal.pone.0009085CrossRefPubMedPubMedCentral

36.

Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, White MB, Noble NA, Monteith P, Fuchs M, Thacker LR, Sikaroodi M, Bajaj JS (2013) Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 58:949–955. https://doi.org/10.1016/j.jhep.2013.01.003CrossRefPubMedPubMedCentral

37.

Ohigashi S, Sudo K, Kobayashi D, Takahashi O, Takahashi T, Asahara T, Nomoto K, Onodera H (2013) Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 58:1717–1726. https://doi.org/10.1007/s10620-012-2526-4CrossRefPubMed

38.

Li C, Huang Q, Yang R, Dai Y, Zeng Y, Tao L, Li X, Zeng J, Wang Q (2019) Gut microbiota composition and bone mineral loss—epidemiologic evidence from individuals in Wuhan, China. Osteoporos Int 30:1003–1013. https://doi.org/10.1007/s00198-019-04855-5CrossRefPubMed

Title: Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women
Authors: D. Ozaki
R. Kubota
T. Maeno
M. Abdelhakim
N. Hitosugi
Publication date: 01-01-2021
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Respiratory Microbiota
Published in: Osteoporosis International / Issue 1/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05728-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women

Abstract

Introduction

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Loss of bone density and bone strength following premenopausal risk–reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study)

Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study

Fracture prediction from FRAX for Canadian ethnic groups: a registry-based cohort study

Physical function in UK adults with osteogenesis imperfecta: a cross-sectional analysis of the RUDY study

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures

Fragility fracture discriminative ability of radius quantitative ultrasound: a systematic review and meta-analysis